CLINICAL_TRIALS
ClinicalTrials.gov record update
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer: a Prospective，Multicentre, Single-arm Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06613165
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:01.304219+00:00
- Published At
- 2024-12-27T00:00:00+00:00
- Record Updated At
- 2024-12-27
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Immune-related Adverse Event", "Neoadjuvant Therapy", "dMMR Colorectal Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-12-27"- protocolSection.identificationModule.nctId
"NCT06613165"- protocolSection.identificationModule.officialTitle
"Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer: a Prospective\uff0cMulticentre, Single-arm Study"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.